A Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

Clinical trial NCT02130557 · COMPLETED

Trial details

NCT number

NCT02130557

Sponsor

Pfizer

Status

COMPLETED

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2014-07-15

Primary completion

2016-08-11

Enrollment

536

View on ClinicalTrials.gov